Vaping among ex-smokers grows sharply as disposable e-cigarettes take hold

Vaping among ex-smokers in England surged from 2% in 2013 to over 20% in 2024, driven by younger demographics and disposable e-cigarettes, raising questions about health implications and smoking relapse.

Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center | Psychedelic Invest

UK sites to participate in part of pivotal phase 3 program following Medicines and Healthcare Regulatory Agency approval of study Research will take place in

November 16, 2023

Unomedical recall of infusion sets tagged as Class I by FDA

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration

November 28, 2023

Sotorasib Promising for KRAS–Related Vascular Malformations

Treating severe KRAS G12C-related arteriovenous malformations with sotorasib (Lumakras) appeared to be effective in a small French study. Two adult patients with the life-threatening condition

July 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.